Propylthiouracil-Induced Hepatotoxicity

Western Journal of Medicine

Volumn 165, Issue 3, 1996, Pages 144-

  Hardee, James T ^a,b,d   Barnett, Angela L ^a,b   Thannoun, Abdul ^a,b   Echtesad, Bijan ^a,c   Wheeler, Donald ^a,c   Jamal, M Mazen ^a,b  

^a Division of Gastroenterology ^*

^b Division of Liver Transplantation

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; PROPYLTHIOURACIL;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; GRAVES DISEASE; HUMAN; LIVER FAILURE; LIVER FUNCTION TEST; TOXIC HEPATITIS;

ADULT; ANTITHYROID AGENTS; BIOPSY; FEMALE; GRAVES DISEASE; HEPATITIS, TOXIC; HUMANS; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; PROPYLTHIOURACIL;

EID: 0030236092     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Livingston HJ, Livingston SF: Agranulocytosis and hepatocellular jaundice: Toxic reaction following propylthiouracil therapy. JAMA 1947; 135:422-425
2. Colwell AR, Sando DE, Lang SI: Propylthiouracil-induced agranulocytosis, toxic hepatitis, and death. JAMA 1952; 148:639-641
3. Eisen MJ: Fulminant hepatitis during treatment with propylthiouracil. N Engl J Med 1953; 249:814-816
4. Parker LN: Hepatitis and propylthiouracil (Letter). Ann Intern Med 1975; 82:228-229
5. Fedotin MS, Lefer LG: Liver disease caused by propylthiouracil. Arch Intern Med 1975; 135:319-321
6. Mihas AA, Holley P, Koff RS, et al: Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. Gastroenterology 1976; 70:770-774
7. Maddrey WC, Boitnott JK: Drug-induced chronic liver disease. Gastroenterology 1977; 72:1348-1353
8. Reddy CM: Propylthiouracil and hepatitis: A case report. J Natl Med Assoc 1979; 71:1185-1186
9. Weiss M, Hassin D, Bank H: Propylthiouracil-induced hepatic damage (Letter). Arch Intern Med 1980; 140:1184-1185
10. Pacini F, Sridama V, Refetoff S: Multiple complications of propylthiouracil treatment: Granulocytopenia, eosinophilia skin reaction, and hepatitis with lymphocyte sensitization. J Endocrinol Invest 1982; 5:403-407
11. Parker WA: Propylthiouracil-induced hepatotoxicity. Clin Pharm 1982; 1:471-474
12. Safani MM, Tatro DS, Rudd P: Fatal propylthiouracil-induced hepatitis. Arch Intern Med 1982; 142:838-839
13. Hanson JS: Propylthiouracil and hepatitis: Two cases and a review of the literature. Arch Intern Med 1984; 144:994-996
14. Vitug AC, Goldman JM: Hepatotoxicity from antithyroid drugs. Horm Res 1985; 21:229-234
15. Garty BZ, Kauli R, Ben-Ari J, Lubin E, Nitzan M, Laron Z: Hepatitis associated with propylthiouracil treatment. Drug Intell Clin Pharm 1985; 19:740-742
16. Bloch CA, Jenski LJ, Balistreri WF: Propylthiouracil-associated hepatitis. Arch Intern Med 1985; 145:2129-2130
17. Seidman DS, Ilie B: Propylthiouracil-induced cholestatic jaundice. Clin Toxicol 1986; 24:353-360
18. Limaye A, Ruffolo PR: Propylthiouracil-induced fatal hepatic necrosis. Am J Gastroenterol 1987; 82:152-154
19. Jonas MM, Eidson MS: Propylthiouracil hepatotoxicity: Two pediatric cases and review of the literature. J Pediatr Gastroenterol Nutr 1988; 7:776-779
20. Baker B, Shapiro B, Fig LM, et al: Unusual complications of antithyroid drug therapy: Four case reports and a review of the literature. Thyroidology 1989; 1:17-26
21. Kirkland JL: Propylthiouracil-induced hepatic failure and encephalopathy in a child. Drug Intell Clin Pharm 1990; 24:470-471
22. Hayashida CY, Duarte AJ, Sato AE, Yamashiro-Kanashiro EH: Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil. J Endocrinol Invest 1990; 13:937-941
23. Peter SA: Propylthiouracil-associated hepatitis. J Natl Med Assoc 1991; 83:75-77
24. Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ: Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism - A cohort study. Ann Intern Med 1993; 118:424-428
25. Westphal SA: Hepatotoxicity from propylthiouracil. South Med J 1994; 87:943-947
26. Maggiore G, Larizza D, Lorini R, De Giacomo C, Scotta MS, Severi F: Propylthiouracil hepatotoxicity mimicking autoimmune chronic active hepatitis in a girl. J Pediatr Gastroenterol Nutr 1989; 8:547-548
27. Lee WM: Drug-induced hepatotoxicity. N Engl J Med 1995; 333:1118-1127
28. Shiran A, Shechner C, Dickstein G: Propylthiouracil-induced agranulocytosis in four patients previously treated with the drug (Letter). JAMA 1991; 266:3129-3130
29. Amrhein JA, Kenny FM, Ross D: Granulccytopenia, lupus-like syndrome and other complications of propylthiouracil therapy. J Pediatr 1970; 76:54-63
30. Bilezikian SB, Laleki Y, Tsan MF, et al: Immunological reactions involving leukocytes: Agranulocytosis induced by antithyroid drugs. Johns Hopkins Med J 1976; 138:124-129
31. Breese TJ, Solomon IL: Granulocytopenia and hemolytic anemia as complications of propylthiouracil therapy. J Pediatr 1975; 86:117-119
32. Aksoy M, Erdem S: Aplastic anaemia after propylthiouracil. Lancet 1968; 1:1379
33. Sammon TJ, Peden VH, Witzleben C, et al: Disseminated intravascular coagulation complicating propylthiouracil therapy - A case description of a 16-year-old girl. Clin Pediatr 1971; 10:739-742
34. Verdy M, Pretty H, Cadotte M, et al: Vasculitis secondary to antithyroids. Union Med Can 1975; 104:576-579
35. Vasily DB, Tyler WB: Propylthiouracil-induced cutaneous vasculitis. JAMA 1980; 243:458-461
36. Miyazono K, Okazaki T, Uchida S, et al: Propylthiouracil-induced diffuse interstitial pneumonitis. Arch Intern Med 1984; 144:1764-1765
37. Movitt E, Gerstl B, Davis A: Needle liver biopsy in thyrotoxicosis. Arch Intern Med 1953; 91:729
38. Czaja AJ: Autoimmune hepatitis and viral infection. Gastroenterol Clin North Am 1994; 23:547-566